Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX   US92532F1003

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Vertex Pharmaceuticals Inc
Discovers and develops novel, small molecule pharmaceuticals

Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets.

It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune diseases, such as rheumatoid arthritis; cancer, inflammatory bowel disease; and neurological disorders, including pain, Huntington's disease and multiple sclerosis.

The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Number of employees : 1 830 persons.
Sales per Businesses
20132014Delta
USD (in Million)%USD (in Million)%
Pharmaceuticals1,212100%580.42100% -108.81%
Sales per Regions
20132014Delta
USD (in Million)%USD (in Million)%
United States896.9574%361.0762.2% -148.41%
Europe279.5623.1%197.6134% -41.47%
Other35.472.9%21.733.7% -63.21%
United Kingdom-----
Managers
NameAgeSinceTitle
Jeff Leiden592009Chairman, President & Chief Executive Officer
Simon Bedson, MBA-2011SVP & GM-International Commercial Operations
Ian F. Smith482001CFO, EVP & Principal Financial Officer
Jeffrey A. Chodakewitz, MD-2014Chief Medical Officer & Executive Vice President
David Matthew Altshuler MD, PhD502012Chief Scientific Officer & EVP-Global Research
Joshua S. Boger, PhD631989Director
Bruce I. Sachs, MBA551998Lead Independent Director
Elaine S. Ullian671997Lead Independent Director
Wayne Joseph Riley MD, MBA552010Independent Director
Margaret G. McGlynn, MBA552011Independent Director
Shareholders
NameShares%
Capital Research & Management Co. (World Investors) 24,608,477 10.2%
Wellington Management Co. LLP 17,194,032 7.10%
The Vanguard Group, Inc. 15,501,687 6.40%
Fidelity Management & Research Co. 13,991,502 5.78%
T. Rowe Price Associates, Inc. 13,290,603 5.49%
BlackRock Fund Advisors 12,105,206 5.00%
SSgA Funds Management, Inc. 10,255,865 4.24%
JPMorgan Investment Management, Inc. 8,666,510 3.58%
Columbia Management Investment Advisers LLC 7,874,406 3.25%
ClearBridge Investments LLC 7,523,625 3.11%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
GILEAD SCIENCES, ..
AMGEN, INC.
ABBVIE INC
CELGENE CORPORATI..
BIOGEN INC
ASTRAZENECA PLC
ALEXION PHARMACEU..
VERTEX PHARMACEUT..
UCB
GRIFOLS SA
JAZZ PHARMACEUTIC..
INDIVIOR PLC
CHONGQING ZHIFEI ..
-
CELLDEX THERAPEUT..
WALVAX BIOTECHNOL..
-
STAIDSON (BEIJING..
GREEN CROSS CORP
MEDY TOX INC
THERAVANCE INC
ARIAD PHARMACEUTI..
Sector Pharmaceuticals
Vertex Pharmaceuticals Inc : Connections
SpiderCloud Wireless, Inc.
Society of Medical Administrators, Inc.
Clarus Ventures LLC
Brigham & Women's Hospital
Massachusetts Workforce Board Association
Center for Nonprofit Management, Inc.
GreatCall, Inc.
The American Institute of Certified Public Accountants
American Cancer Society, Inc.
Institute of Chartered Accountants in England & Wales
American Academy of Arts & Sciences
The Financial Executives Institute
Nantero, Inc.
Biotechnology Industry Organization
DataGravity, Inc.
Infectious Diseases Society of America
The Boston Private Industry Council, Inc.
The American Society for Clinical Pharmacology & Therapeutics
Tennessee Institute of Public Health
Massachusetts Mutual Life Insurance Co.
Federal Reserve Bank of Atlanta
Ravinia Festival Association
National Academy of Sciences
Vertex Pharmaceuticals
New England Aquarium Corp.
Massachusetts Institute of Technology
WGBH Educational Foundation
The Broad Institute, Inc.
Massachusetts Life Sciences Center
Biolex Therapeutics, Inc.
Accelerated Cure Project for Multiple Sclerosis
Association of Minority Health Professions Schools, Inc.
SimpliVity Corp.
Macp Organization
Tonian Systems, Inc.
The Nashville Symphony Association
Charles River Ventures, Inc.
Whitehead Institute for Biomedical Research
American Society for Clinical Investigation
American College of Physicians
Association of American Physicians
Alkeus Pharmaceuticals, Inc.
Nashville Area Chamber of Commerce
New England Healthcare Institute
United Way of Metropolitan Nashville
Harvard Medical School
Cheekwood Botanical Gardens & Museum of Art
Wesleyan University
Nashville Health Care Council
Celebrity Series of Boston, Inc.
Middle Tennessee Council, Inc.
The Hastings Center
Alpha Omega Alpha Honor Medical Society
Massachusetts Life Sciences Collaborative
Vanderbilt University School of Medicine
The Alliance for Business Leadership
International AIDS Vaccine Initiative, Inc.
Museum of Science
American Civil Liberties Union Foundation, Inc.
Abington Friends School
Company contact information
50 avenue Northern
US-MA 02110 Boston, Massachusetts
États-Unis (les)

Phone : +1 617 444 6100
Fax : +1 617 444 6680
Internet : http://www.vpharm.com
Markets and indexes
- NASDAQ All Markets
- Nasdaq Global Select Market
- Nasdaq 100 / SP500
Stock Exchange Codes
- ISIN Code :  US92532F1003
- Bloomberg Code :  VRTX:US
- Reuters Code :  VRTX.O
- Datastream Code :  
© 2015 People , Fundamentals and Ownership    © 2015 Cofisem   
Dynamic quotes  
ON
| OFF